| Raymond
S Fersko, Esq. Managing Member . |
|
He has a diverse practice counseling corporations, academic institutions, government, agencies, life science investors and not for profit research foundations in transactional, litigation and regulatory compliance. Mr. Fersko has represented companies before the FDA; negotiated Cooperative Research and Development Agreements (CRADAs), with and for universities, the US government and others who license technology. He negotiated the first CRADA for an AIDS vaccine with two institutes of NIH in 1986 and has worked with, the CDC, Army, and NASA. Mr. Fersko has more than 30 years of experience. He has litigated complex international, antitrust, libel, corporate, trademark and patent infringement cases. He has also litigated antitrust cases involving, among other matters, Primary Dealers' trading of government bonds, and the recording industry. In addition, he has represented parties in aircrash and commercial litigation in the airline industry, and estate litigation involving repatriation of assets. He has also represented Polygram Records in connection with record industry "payola" investigations by U.S. attorneys in several U.S. jurisdictions and defendants in securities fraud cases brought by the United States Attorney for the Southern District of New York, the U.S. Securities and Exchange Commission and the Attorney General of the state of New York. Mr. Fersko is an internationally published expert on legal and business issues affecting life science companies; he is a Contributing Editor of the Journal of Law and Biotechnology and a frequent speaker at industry forums in the U.S. and Europe. Mr. Fersko is admitted to practice in state and federal Courts of New York, the District of Columbia and the United States Supreme Court, where he successfully obtained a reversal and remand of and to the New York Court of Appeals. He is a member of the Bar Association of the City of New York, County and State of New York, the International Bar Association, the American Bar Association and the Licensing Executives Society International. He received his J.D. (1972) from American University, where he was Associate Editor of the Law Review; and completed a graduate economics seminar at George Washington University. He is an adjunct professor of Biotech Law at the Washington College of Law at the American University. He has also lectured at Georgetown University Law School, City University of New York, Columbia University, Foundation for Advanced Education in the Sciences, the NIH Graduate School, Harvard University School of Public Health, and the Center for International Legal Studies in Salzburg, Austria.
© Ferskos LLC. Terms of Use |